BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 23293112)

  • 1. Long-term outcome for gastric marginal zone lymphoma treated with radiotherapy: a retrospective, multi-centre, International Extranodal Lymphoma Study Group study.
    Wirth A; Gospodarowicz M; Aleman BM; Bressel M; Ng A; Chao M; Hoppe RT; Thieblemont C; Tsang R; Moser L; Specht L; Szpytma T; Lennard A; Seymour JF; Zucca E
    Ann Oncol; 2013 May; 24(5):1344-51. PubMed ID: 23293112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes After Reduced-Dose Intensity Modulated Radiation Therapy for Gastric Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma.
    Pinnix CC; Gunther JR; Milgrom SA; Cruz Chamorro RJ; Medeiros LJ; Khoury JD; Amini B; Neelapu S; Lee HJ; Westin J; Fowler N; Nastoupil L; Dabaja B
    Int J Radiat Oncol Biol Phys; 2019 Jun; 104(2):447-455. PubMed ID: 30769175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stage I and II MALT lymphoma: results of treatment with radiotherapy.
    Tsang RW; Gospodarowicz MK; Pintilie M; Bezjak A; Wells W; Hodgson DC; Crump M
    Int J Radiat Oncol Biol Phys; 2001 Aug; 50(5):1258-64. PubMed ID: 11483337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective study of 5-year outcomes of radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma refractory to Helicobacter pylori eradication therapy.
    Abe S; Oda I; Inaba K; Suzuki H; Yoshinaga S; Nonaka S; Morota M; Murakami N; Itami J; Kobayashi Y; Maeshima AM; Saito Y
    Jpn J Clin Oncol; 2013 Sep; 43(9):917-22. PubMed ID: 23878345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective Phase II trial of radiation therapy in localised non-gastric marginal zone lymphoma with prospective evaluation of autoimmunity and Helicobacter pylori status: TROG 05.02/ALLG NHL15.
    MacManus MP; Roos D; O'Brien P; Capp A; Wirth A; Tsang R; Bressel M; Lade S; Seymour JF
    Eur J Cancer; 2021 Jul; 152():129-138. PubMed ID: 34098462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma refractory to Helicobacter pylori eradication therapy.
    Sugimoto M; Kajimura M; Shirai N; Furuta T; Kanaoka S; Ikuma M; Sato Y; Hishida A
    Intern Med; 2006; 45(6):405-9. PubMed ID: 16617193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiotherapy for low-grade gastric marginal zone lymphoma: a retrospective study.
    Lin ML; Wirth A; Chao M; Milner AD; DiIulio J; MacManus M; Seymour JF
    Intern Med J; 2007 Mar; 37(3):172-80. PubMed ID: 17316336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of a retrospective study on radiotherapy for gastric mucosa-associated lymphoid tissue lymphoma].
    Ghorbal L; Hdiji A; Ben Salah H; Elloumi F; Frikha M; Elloumi M; Daoud J
    Cancer Radiother; 2018 Dec; 22(8):763-766. PubMed ID: 30337049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete long-term response to radiotherapy of gastric early-stage marginal zone lymphoma resistant to both anti-Helicobacter pylori antibiotics and chemotherapy.
    Gobbi PG; Corbella F; Valentino F; Bergonzi M; Sangalli C; Perfetti V; Corazza GR
    Ann Oncol; 2009 Mar; 20(3):465-8. PubMed ID: 19074214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation therapy for localized low-grade non-Hodgkin's lymphomas.
    Tsang RW; Gospodarowicz MK
    Hematol Oncol; 2005 Mar; 23(1):10-7. PubMed ID: 16158458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Favorable radiation field decrease in gastric marginal zone lymphoma : Experience of the German Study Group on Gastrointestinal Lymphoma (DSGL).
    Reinartz G; Pyra RP; Lenz G; Liersch R; Stüben G; Micke O; Willborn K; Hess CF; Probst A; Fietkau R; Jany R; Schultze J; Rübe C; Hirt C; Fischbach W; Bentz M; Daum S; Pott C; Tiemann M; Möller P; Neubauer A; Wilhelm M; Willich N; Berdel WE; Eich HT
    Strahlenther Onkol; 2019 Jun; 195(6):544-557. PubMed ID: 30859254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term clinical outcome of Helicobacter pylori eradication for gastric mucosa-associated lymphoid tissue lymphoma with a reference to second-line treatment.
    Nakamura S; Matsumoto T; Suekane H; Nakamura S; Matsumoto H; Esaki M; Yao T; Iida M
    Cancer; 2005 Aug; 104(3):532-40. PubMed ID: 15937928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exclusive moderate-dose radiotherapy in gastric marginal zone B-cell MALT lymphoma: Results of a prospective study with a long term follow-up.
    Ruskoné-Fourmestraux A; Matysiak-Budnik T; Fabiani B; Cervera P; Brixi H; Le Malicot K; Nion-Larmurier I; Fléjou JF; Hennequin C; Quéro L;
    Radiother Oncol; 2015 Oct; 117(1):178-82. PubMed ID: 26395311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term clinical outcome of gastric MALT lymphoma after eradication of Helicobacter pylori: a multicentre cohort follow-up study of 420 patients in Japan.
    Nakamura S; Sugiyama T; Matsumoto T; Iijima K; Ono S; Tajika M; Tari A; Kitadai Y; Matsumoto H; Nagaya T; Kamoshida T; Watanabe N; Chiba T; Origasa H; Asaka M;
    Gut; 2012 Apr; 61(4):507-13. PubMed ID: 21890816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of gastric mucosa-associated lymphoid tissue lymphoma in patients with extra copies of the
    Iwamuro M; Takenaka R; Nakagawa M; Moritou Y; Saito S; Hori S; Inaba T; Kawai Y; Toyokawa T; Tanaka T; Yoshino T; Okada H
    World J Gastroenterol; 2017 Sep; 23(33):6155-6163. PubMed ID: 28970731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single-center study of treatment outcomes and survival in patients with primary gastric lymphomas between 1990 and 2003.
    Jezersek Novaković B; Vovk M; Juznic Setina T
    Ann Hematol; 2006 Dec; 85(12):849-56. PubMed ID: 16944146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes and patterns of relapse of early-stage extranodal marginal zone lymphoma treated with radiation therapy with curative intent.
    Teckie S; Qi S; Lovie S; Navarrett S; Hsu M; Noy A; Portlock C; Yahalom J
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):130-7. PubMed ID: 25863760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results of stomach-conserving therapy in gastric MALT lymphoma.
    Vrieling C; de Jong D; Boot H; de Boer JP; Wegman F; Aleman BM
    Radiother Oncol; 2008 Jun; 87(3):405-11. PubMed ID: 18343513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series.
    Fischbach W; Goebeler-Kolve ME; Dragosics B; Greiner A; Stolte M
    Gut; 2004 Jan; 53(1):34-7. PubMed ID: 14684573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective analysis of efficacy and long-term outcome of radiation therapy for gastric mucosa-associated lymphoid tissue lymphoma.
    Okada H; Takemoto M; Kawahara Y; Nasu J; Takenaka R; Kawano S; Inoue M; Ichimura K; Tanaka T; Shinagawa K; Yoshino T; Yamamoto K
    Digestion; 2012; 86(3):179-86. PubMed ID: 22907329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.